TXNIP and lung adenocarcinoma: Specifically, the research will delve into how NCL modulates tumor immune escape through the MYC/TXNIP axis, elucidating the molecular mechanisms of NCL in the immune evasion process in lung adenocarcinoma (Song et al. 2022a, b; Seephan et al. 2023).